Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

NCT00826800 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Colon Cancer

Interventions

DRUG: FOLFOX and bevacizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]